Bioorganometallic chemistry--from teaching paradigms to medicinal applications.
about
Magnetically recoverable ruthenium catalysts in organic synthesisMapping the protein-binding sites for iridium(iii)-based CO-releasing moleculesUnusual mode of protein binding by a cytotoxic π-arene ruthenium(ii) piano-stool compound containing an O,S-chelating ligandAnionic chlorido(triphenyl)tin(IV) bearing N-phthaloylglycinato or 1,2,4-benzenetricarboxylato 1,2-anhydride ligands: potential cytotoxic and apoptosis-inducing agents against several types of cancer.In-Cell Activation of Organo-Osmium(II) Anticancer Complexes.Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activity.An organometallic structure-activity relationship study reveals the essential role of a Re(CO)3 moiety in the activity against gram-positive pathogens including MRSA.Enhanced Cytotoxicity through Conjugation of a "Clickable" Luminescent Re(I) Complex to a Cell-Penetrating LipopeptideSynthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors.Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier.A tandem mass spectrometric investigation of N-(3-ferrocenyl-2-naphthoyl) dipeptide ethyl esters and N-(6-ferrocenyl-2-naphthoyl) dipeptide ethyl esters.Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity.Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.Molecules of ruthenium-based olefin metathesis catalysts as two- and three-photon absorbers.Organometallic anticancer compoundsA metal-based inhibitor of NEDD8-activating enzyme.Mirror-image organometallic osmium arene iminopyridine halido complexes exhibit similar potent anticancer activity.New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity.Organometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors.Conjugation of organoruthenium(II) 3-(1H-benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and indolo[3,2-d]benzazepines to recombinant human serum albumin: a strategy to enhance cytotoxicity in cancer cells.Transition Metal Complexes of Naproxen: Synthesis, Characterization, Forced Degradation Studies, and Analytical Method VerificationAnticancer Activity of Self-Assembled Molecular Rectangles via Arene-Ruthenium Acceptors and a New Unsymmetrical Amide LigandHexanuclear self-assembled arene-ruthenium nano-prismatic cages: potential anticancer agents.Metal-Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular Accumulation.A valence bond model for aqueous Cu(II) and Zn(II) ions in the AMOEBA polarizable force fieldNovel enantiopure cyclopentadienyl Ti(IV) oximato compounds as potential anticancer agents.Ferrocenyl 2,5-Piperazinediones as Tubulin-Binding Organometallic ABCB1 and ABCG2 Inhibitors Active against MDR Cells.Dicopper(II) and dizinc(II) complexes with nonsymmetric dinucleating ligands based on indolo[3,2-c]quinolines: synthesis, structure, cytotoxicity, and intracellular distribution.Metal-containing and related polymers for biomedical applications.In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites.Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies.Application of metal coordination chemistry to explore and manipulate cell biology.Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity.Anticancer activity of metal complexes: involvement of redox processes.Developing drug molecules for therapy with carbon monoxide.Small organometallic compounds as antibacterial agents.Capillary electrophoretic methods in the development of metal-based therapeutics and diagnostics: new methodology and applications.Organometallic compounds: an opportunity for chemical biology?Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends.Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs.
P2860
Q27021316-3A9E6963-790E-43FC-9D76-60466F521034Q27719016-40511C8E-C796-4C37-8631-E66854CEC69DQ27720200-D387F970-3D66-4910-9F22-85E21D87EE5FQ30313823-6CC4D562-D2A7-4C12-BA14-214FCDF4C134Q33626165-93F87F7A-C62C-4642-8A60-2B8FEADAE418Q33640724-2605629D-2DA4-4917-AB04-FA530F8A5BCEQ33691622-9562A4A9-20A3-4B97-AFF8-0A1737777D1CQ33889086-77F4CB5D-B0D2-498A-AA37-CCDBEA9E06F0Q33900124-F58144CB-3D1E-444C-A7CC-15F625386C01Q33991566-BA1109D2-3FBD-40BC-AD03-E79159FCE41BQ34018159-FCF870A0-4D63-4290-8295-32AC6F2F583DQ34128946-106C7150-5678-490D-B060-DE0AC708F719Q34415646-85993626-6818-4D31-B808-0E1FD7F870CDQ34420682-DDEBF139-1BA9-4EA5-AD0C-9CF5E1A867EDQ34476685-C17F58CC-14D4-49CD-A963-DF936792B7D4Q34490186-473C8705-2399-455D-871C-1EE33F9C4E11Q34795234-DE67BF85-D082-4841-8A98-2B41B915B5CCQ35029887-A41B5822-4AEA-4DF7-9533-4B07889AF427Q35207714-9A4369BE-5A11-4241-AC6C-5CDEEB2ECE9AQ35664830-8D260920-F984-4C9D-B5AD-EAA7EFC88E5FQ35976205-954487AE-4260-4812-8CB9-3CBA4D9B760BQ35983960-28274138-9937-4737-A004-D21B31F03C3AQ36232940-8621AF5D-3277-4A53-93E9-448DE9CE5268Q36613535-8800B33D-81C9-4D45-B203-5803A9432C74Q36644630-16DFD1D6-871B-4AA0-807F-BA2DF020D3C7Q36942237-59FC4973-59D8-4ADD-B43D-3BBC53140609Q36996281-4FFE52EC-03D8-418D-A63D-604F8147E116Q37148450-875F6051-68E7-48D6-AB8C-5B0009EB6E7DQ37201391-3F50D2D9-2913-4971-B6A2-1C191CE9BEEEQ37263372-73CBCEAA-0EF7-4A9A-8FDC-F1F3131647D1Q37337277-3F992DC4-C7F4-4E57-86F6-3DD5F54A5055Q37387617-BA2A85BE-6FD6-42CC-A0EA-7EA23C39E9A0Q37657640-B40EFCDF-6A50-42BB-B9C3-B4650B86F90AQ37833099-0C679D33-AB55-45CF-9348-297FD3EA46B0Q37986364-0C9DDEDF-A04A-40BB-9A29-CF017FDA7DB8Q37992889-AAEA6C9B-CA8F-4AC4-8F07-C869801D08EEQ37997361-53DA7B91-1CD6-43E3-9B8A-6FD0F3DB77CAQ38012429-2C76A836-72EC-41E0-9563-C91CA2315FD4Q38052406-17D99BCD-A266-40A1-982C-F4E4C2208DAEQ38105454-0835A8AE-2867-4E4F-820B-838F0A275EB2
P2860
Bioorganometallic chemistry--from teaching paradigms to medicinal applications.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Bioorganometallic chemistry--from teaching paradigms to medicinal applications.
@en
Bioorganometallic chemistry--from teaching paradigms to medicinal applications.
@nl
type
label
Bioorganometallic chemistry--from teaching paradigms to medicinal applications.
@en
Bioorganometallic chemistry--from teaching paradigms to medicinal applications.
@nl
prefLabel
Bioorganometallic chemistry--from teaching paradigms to medicinal applications.
@en
Bioorganometallic chemistry--from teaching paradigms to medicinal applications.
@nl
P2860
P356
P1476
Bioorganometallic chemistry--from teaching paradigms to medicinal applications.
@en
P2860
P304
P356
10.1039/B707077M
P577
2008-11-25T00:00:00Z